Back to top
more

State Street SPDR S&P Pharmaceuticals ETF: (XPH)

(Delayed Data from NYSE) As of Jul 16, 2026 04:00 PM ET

$67.09 USD

67.09
56,056

-0.87 (-1.28%)

Volume: 56,056

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $67.36 +0.27 (0.40 %) 7:58 PM ET

Zacks News

Zacks Equity Research

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XPH

Zacks Equity Research

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

by Zacks Equity Research

Sector ETF report for XPH

Zacks Equity Research

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XPH

Zacks Equity Research

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

by Zacks Equity Research

Sector ETF report for XPH

Zacks Equity Research

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XPH

Zacks Equity Research

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

by Zacks Equity Research

Sector ETF report for XPH

Sanghamitra Saha headshot

3 Undervalued ETFs to Buy Before 2026

by Sanghamitra Saha

Worried about high valuations? KBE, XRT, and XPH with low P/Es and fresh momentum are three undervalued ETFs to consider as 2026 approaches.

Sanghamitra Saha headshot

Pharma ETF (XPH) Hits a New 52-Week High

by Sanghamitra Saha

Pharma ETF XPH hits a fresh 52-week high as healthcare shines amid AI bubble fears and slowing growth. Biotech M&A adds fuel -- can momentum hold?

Zacks Equity Research

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

by Zacks Equity Research

Sector ETF report for XPH

Zacks Equity Research

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XPH